Additionally, dysregulation of liver factors (primarily fetuin-A), fibroblast growth factor-21 (FGF-21), and selenoprotein P1 (SEPP1) contributes to the development of MASLD, alterations in lipid metabolism, and increased oxidative stress in women with PCOS. This evidence concerns the gene FGF21 and polycystic ovary syndrome.